Search results
Results From The WOW.Com Content Network
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs.
Zydus Wellness (previously Carnation Nutra-Analogue Foods) is an Indian consumer goods company headquartered in Ahmedabad, which produces nutrition and skincare products. It is a subsidiary of the pharmaceutical company Zydus Lifesciences (formerly known as Cadila Healthcare).
India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the multi-billion dollar market for treating a type of liver disease ...
Zydus Lifesciences and Sun Pharmaceuticals have entered an agreement in October 2023 to co-market Desidustat. Sun Pharma will sell the drug as Rytstat, while Zydus will continue to sell it as Oxemia. [6]
He took charge in 1995 after a formal separation between the two founding families from Zydus Cadila to Zydus Lifesciences and Cadila Healthcare. [8] When he took over the Cadila Healthcare, he was faced with two challenges: His was a Rs. 200-crore company whereas his overheads including management, research, company expenses, and staff worked ...
products and services, more choices, and greater innovation. Because of the importance of health care competition to the economy and consumer welfare, anticompetitive conduct in health care markets has long been a key target of FTC law enforcement,6 research,7 and
10 products to make groceries last longer — and save you money. The best skin care routine for your 60s, according to dermatologists. Show comments. Advertisement. Advertisement. In Other News.
The products are based upon the company's molecular modeling software for optimizing protein structure. [ 1 ] [ 2 ] [ 3 ] In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. [ 4 ]